Loading
Latest filing published 02 Jun 2018 for Genix Pharmaceutical Corp., €6,603.
No signal scores available.
Charles Richard Chebry discloses dealings in Genix Pharmaceutical Corp. to SEDI. The record holds 2 filings, for trades running from 31 May 2018 to 1 June 2018.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 2 June 2018: a transaction of €6,603, in Genix Pharmaceutical Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations